BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35803847)

  • 21. Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study.
    Zhang D; Petigara T; Yang X
    BMC Infect Dis; 2018 Aug; 18(1):436. PubMed ID: 30157781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(40):816-9. PubMed ID: 23051612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7.
    Singleton JA; Greby SM; Wooten KG; Walker FJ; Strikas R
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):39-62. PubMed ID: 11016877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.
    Vila-Córcoles A; Ochoa-Gondar O; de Diego C; Satué E; Vila-Rovira A; Aragón M
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: A retrospective database analysis.
    Yang X; Zhang D; Ou W
    Vaccine; 2018 Nov; 36(49):7574-7579. PubMed ID: 30391053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.
    Burns CM; Banks RE; Wilson BM; Carter RR; Jump RLP; Perez F
    AIDS Care; 2018 Feb; 30(2):146-149. PubMed ID: 29052434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine.
    Hsiao A; Hansen J; Timbol J; Lewis N; Isturiz R; Alexander-Parrish R; McLaughlin JM; Gessner BD; Klein NP
    JAMA Netw Open; 2022 Mar; 5(3):e221111. PubMed ID: 35302634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
    Gidding HF; McCallum L; Fathima P; Moore HC; Snelling TL; Blyth CC; Jayasinghe S; Giele C; de Klerk N; Andrews RM; McIntyre PB;
    Vaccine; 2018 May; 36(19):2650-2656. PubMed ID: 29627233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study.
    Ochoa-Gondar O; Hospital I; Vila-Corcoles A; Aragon M; Jariod M; de Diego C; Satue E;
    BMC Public Health; 2017 Jun; 17(1):610. PubMed ID: 28662648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of long-term-care facility residents associated with receipt of influenza and pneumococcal vaccinations.
    Bardenheier B; Shefer A; McKibben L; Roberts H; Bratzler D
    Infect Control Hosp Epidemiol; 2004 Nov; 25(11):946-54. PubMed ID: 15566029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
    Wyplosz B; Fernandes J; Sultan A; Roche N; Roubille F; Loubet P; Fougère B; Moulin B; Duhot D; Vainchtock A; Raguideau F; Lortet-Tieulent J; Blanc E; Moïsi J; Goussiaume G
    Vaccine; 2022 Aug; 40(33):4911-4921. PubMed ID: 35811205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of an intervention to improve the vaccination coverage against
    Hernández-García I; Román-Calderón F; López-Mendoza H; Aibar-Remón C;
    Rev Esp Salud Publica; 2019 Dec; 93():. PubMed ID: 31782756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
    Giese C; Mereckiene J; Danis K; O'Donnell J; O'Flanagan D; Cotter S
    Vaccine; 2016 Jul; 34(32):3657-62. PubMed ID: 27255466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(43):1477-81. PubMed ID: 22048728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
    Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
    Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study "diaVAX".
    Satman I; Akalin S; Cakir B; Altinel S;
    Hum Vaccin Immunother; 2013 Dec; 9(12):2618-26. PubMed ID: 23887188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Milucky J; Carvalho MG; Rouphael N; Bennett NM; Talbot HK; Harrison LH; Farley MM; Walston J; Pimenta F; Lessa FC;
    Vaccine; 2019 Feb; 37(8):1094-1100. PubMed ID: 30685247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.